BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 364 filers reported holding BIO-TECHNE CORP in Q2 2019. The put-call ratio across all filers is 7.53 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $168,578,894 | -5.1% | 2,476,552 | +13.8% | 0.04% | 0.0% |
| Q2 2023 | $177,598,230 | +5.1% | 2,175,649 | -4.5% | 0.04% | 0.0% |
| Q1 2023 | $168,947,749 | -12.7% | 2,277,230 | -2.5% | 0.04% | -15.9% |
| Q4 2022 | $193,477,228 | +28.8% | 2,334,426 | +341.4% | 0.04% | +22.2% |
| Q3 2022 | $150,194,000 | -19.6% | 528,851 | -1.9% | 0.04% | -16.3% |
| Q2 2022 | $186,876,000 | -18.3% | 539,109 | +2.0% | 0.04% | -2.3% |
| Q1 2022 | $228,829,000 | +0.8% | 528,424 | +20.5% | 0.04% | +7.3% |
| Q4 2021 | $226,946,000 | +2.9% | 438,681 | -3.6% | 0.04% | -4.7% |
| Q3 2021 | $220,561,000 | -8.4% | 455,171 | -14.8% | 0.04% | -8.5% |
| Q2 2021 | $240,684,000 | +19.5% | 534,544 | +1.4% | 0.05% | +14.6% |
| Q1 2021 | $201,386,000 | +54.5% | 527,284 | +28.5% | 0.04% | +46.4% |
| Q4 2020 | $130,326,000 | +15.6% | 410,413 | -9.8% | 0.03% | 0.0% |
| Q3 2020 | $112,691,000 | -8.0% | 454,897 | -1.9% | 0.03% | -15.2% |
| Q2 2020 | $122,474,000 | +43.5% | 463,796 | +3.1% | 0.03% | +17.9% |
| Q1 2020 | $85,319,000 | -13.1% | 449,949 | +0.6% | 0.03% | +12.0% |
| Q4 2019 | $98,154,000 | +9.5% | 447,161 | -2.3% | 0.02% | 0.0% |
| Q3 2019 | $89,601,000 | -8.4% | 457,919 | -2.4% | 0.02% | -7.4% |
| Q2 2019 | $97,786,000 | +6.5% | 469,012 | +1.5% | 0.03% | +3.8% |
| Q1 2019 | $91,783,000 | +33.3% | 462,263 | -2.8% | 0.03% | +18.2% |
| Q4 2018 | $68,856,000 | -34.0% | 475,791 | -6.9% | 0.02% | -18.5% |
| Q3 2018 | $104,283,000 | +39.5% | 510,911 | +1.1% | 0.03% | +35.0% |
| Q2 2018 | $74,781,000 | -2.7% | 505,444 | -0.7% | 0.02% | -4.8% |
| Q1 2018 | $76,883,000 | +21.6% | 509,020 | +4.3% | 0.02% | +23.5% |
| Q4 2017 | $63,219,000 | +4.3% | 487,997 | -2.7% | 0.02% | 0.0% |
| Q3 2017 | $60,603,000 | +3.4% | 501,317 | +0.5% | 0.02% | 0.0% |
| Q2 2017 | $58,588,000 | +16.6% | 498,619 | +0.8% | 0.02% | +21.4% |
| Q1 2017 | $50,262,000 | +3.0% | 494,459 | +4.2% | 0.01% | 0.0% |
| Q4 2016 | $48,782,000 | -2.2% | 474,395 | +4.1% | 0.01% | -6.7% |
| Q3 2016 | $49,893,000 | -2.8% | 455,658 | +0.1% | 0.02% | -6.2% |
| Q2 2016 | $51,326,000 | +16.7% | 455,139 | -2.2% | 0.02% | +23.1% |
| Q1 2016 | $43,981,000 | +8.2% | 465,298 | +3.0% | 0.01% | +8.3% |
| Q4 2015 | $40,648,000 | -5.5% | 451,626 | -2.9% | 0.01% | -7.7% |
| Q3 2015 | $43,025,000 | -3.5% | 465,339 | +2.8% | 0.01% | +8.3% |
| Q2 2015 | $44,579,000 | +1.9% | 452,714 | +3.8% | 0.01% | +9.1% |
| Q1 2015 | $43,732,000 | +13.9% | 436,045 | +4.9% | 0.01% | +10.0% |
| Q4 2014 | $38,402,000 | – | 415,609 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ownership Capital B.V. | 840,131 | $363,810,000 | 4.80% |
| Montanaro Asset Management Ltd | 89,950 | $38,952,000 | 4.80% |
| Sandhill Capital Partners LLC | 109,939 | $47,608,000 | 4.09% |
| Brown Capital Management | 918,328 | $397,673,000 | 3.96% |
| STONE RUN CAPITAL, LLC | 22,325 | $9,668,000 | 3.57% |
| DF DENT & CO INC | 686,484 | $297,275,000 | 3.42% |
| Westwind Capital | 27,741 | $12,013,000 | 3.23% |
| MAIRS & POWER INC | 657,962 | $284,924,000 | 2.87% |
| Summit Creek Advisors LLC | 58,133 | $25,174,000 | 2.85% |
| Pembroke Management, LTD | 76,250 | $33,019,000 | 2.76% |